Lataa...
Pramipexole use and the risk of pneumonia
BACKGROUND: Patients with Parkinson's disease have an elevated risk of pneumonia and randomized trials suggest that this risk may be increased with the dopamine agonist pramipexole. It is uncertain whether pramipexole or other dopamine agonists increase the risk of pneumonia. METHODS: We used t...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3522019/ https://ncbi.nlm.nih.gov/pubmed/23020246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-12-113 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|